The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of carbadox in medicated swine feed. This action is based on CVM's determination that the use of carbadox under the approved conditions of use results in residues of carcinogenic concern in the edible tissues of the treated swine.
Document
Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing
The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of ...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 21559
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing,” thefederalregister.org (April 12, 2016), https://thefederalregister.org/documents/2016-08327/phibro-animal-health-corp-carbadox-in-medicated-swine-feed-opportunity-for-hearing.